Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial
H Halawi, D Khemani, D Eckert, J O'Neill… - The Lancet …, 2017 - thelancet.com
Background Liraglutide, a long-acting GLP-1 receptor agonist, is approved for treatment of
obesity; however, the mechanisms of action of liraglutide are incompletely understood. We
compared effects of liraglutide versus placebo on gastric motor functions, satiation, satiety,
and weight in obese individuals over 16 weeks. Methods We did a randomised, double-
blind, placebo-controlled pilot trial at a single centre (Mayo Clinic, Rochester, MN, USA).
Participants were randomly allocated (1: 1) by a computer generated randomisation …
obesity; however, the mechanisms of action of liraglutide are incompletely understood. We
compared effects of liraglutide versus placebo on gastric motor functions, satiation, satiety,
and weight in obese individuals over 16 weeks. Methods We did a randomised, double-
blind, placebo-controlled pilot trial at a single centre (Mayo Clinic, Rochester, MN, USA).
Participants were randomly allocated (1: 1) by a computer generated randomisation …
以上显示的是最相近的搜索结果。 查看全部搜索结果